Microscope

Eloxx Pharmaceuticals Reports Third Quarter 2023 Financial and Operating Results and Provides Business Update

Retrieved on: 
Monday, November 13, 2023

WATERTOWN, Mass., Nov. 13, 2023 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc. (OTC: ELOX), a leader in ribosomal RNA-targeted genetic therapies for rare diseases, today reported its financial results for the three months ended September 30, 2023, and provided a business update.

Key Points: 
  • WATERTOWN, Mass., Nov. 13, 2023 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc. (OTC: ELOX), a leader in ribosomal RNA-targeted genetic therapies for rare diseases, today reported its financial results for the three months ended September 30, 2023, and provided a business update.
  • Data from the Phase 2 study of ELX-02 for Alport Syndrome was included in two presentations at the American Society of Nephrology (ASN) Kidney Week 2023.
  • R&D expenses were $1.3 million for the three months ended September 30, 2023, which included $0.1 million in stock-based compensation.
  • Additionally, we sold shares of common stock through our ATM program during the quarter for gross proceeds of $1.8 million.

Consensus Cloud Solutions to Participate at the 42nd Annual J.P. Morgan Healthcare Conference in January 2024

Retrieved on: 
Monday, December 18, 2023

Consensus Cloud Solutions, Inc. (NASDAQ: CCSI) today announced its participation at the 42nd Annual J.P. Morgan Healthcare Conference in January 2024.

Key Points: 

Consensus Cloud Solutions, Inc. (NASDAQ: CCSI) today announced its participation at the 42nd Annual J.P. Morgan Healthcare Conference in January 2024.
Details of the conference are as follows:

Zafrens Launches with $23M in Financing to Advance Multiple Stages of Drug Discovery in a Single Experiment at Unprecedented Scale

Retrieved on: 
Monday, December 11, 2023

The financing will be used to optimize breakthrough applications of the company’s Z-Screen™ platform and advance an internal pipeline.

Key Points: 
  • The financing will be used to optimize breakthrough applications of the company’s Z-Screen™ platform and advance an internal pipeline.
  • Complex cellular co-culture interactions can now be resolved at the molecular and functional levels simultaneously.
  • Large CRISPR, CAR-T, mRNA libraries, or endogenous molecular heterogeneity, can be mapped to their individual manifestations as cell behavior, cell-cell interactions and secretions.
  • Iterative drug discovery can now be replaced with exhaustive combinatorial profiling at extremely high resolution,” said Swamy Vijayan, CEO, Zafrens.

Optical Genome Mapping Market Research Report 2023 - ResearchAndMarkets.com

Retrieved on: 
Thursday, December 7, 2023

The "Optical Genome Mapping Market Size, Share & Trends Analysis Report, By Product (Instruments, Software), By Application (Structural Variant Detection, Genome Assembly), By End-user, By Region, And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Optical Genome Mapping Market Size, Share & Trends Analysis Report, By Product (Instruments, Software), By Application (Structural Variant Detection, Genome Assembly), By End-user, By Region, And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.
  • The global optical genome mapping market size is estimated to reach USD 656.2 million by 2030.
  • The ability of optical genome mapping (OGM) to complement other genomic sequencing technologies, such as next-generation sequencing (NGS), has created synergies in genomics research.
  • Researchers can integrate optical mapping data with NGS data to obtain a more comprehensive view of the genome, which is particularly valuable in clinical diagnostics and cancer research.

Qrypt Partners with Los Alamos National Labs to Advance Quantum Random Number Generation Technology

Retrieved on: 
Thursday, December 7, 2023

Qrypt , the pioneering quantum-secure encryption company, has completed its Cooperative Research and Development Agreement (CRADA) with Los Alamos National Labs (LANL) to develop Qrypt’s state-of-the-art Quantum Random Number Generation (QRNG).

Key Points: 
  • Qrypt , the pioneering quantum-secure encryption company, has completed its Cooperative Research and Development Agreement (CRADA) with Los Alamos National Labs (LANL) to develop Qrypt’s state-of-the-art Quantum Random Number Generation (QRNG).
  • This technology enables Qrypt’s cloud-based Quantum Entropy and Quantum Key Generation services with true quantum randomness to deliver reliable cryptographic security at scale, protecting data from the threat of quantum computing.
  • Qrypt addresses this data vulnerability by harnessing the inherent unpredictability of quantum mechanics to produce truly unpredictable random numbers.
  • “Los Alamos National Laboratory applies cutting edge science and technology to address critical national security challenges.

Agilent BioTek Cytation C10 Confocal Imaging Reader Enhanced with Innovative Water Immersion Technology

Retrieved on: 
Monday, December 4, 2023

Agilent Technologies Inc. (NYSE: A) today announced the addition of water immersion and new confocal spinning disk technology to the BioTek Cytation C10 confocal imaging reader .

Key Points: 
  • Agilent Technologies Inc. (NYSE: A) today announced the addition of water immersion and new confocal spinning disk technology to the BioTek Cytation C10 confocal imaging reader .
  • In light microscopy, water immersion technology automatically and consistently places a layer of water between the objective lens and the sample.
  • Spinning disk confocal technology improves microscopic images by blocking out-of-focus light from reaching the image sensor.
  • Additionally, integrating it with the Agilent BioTek BioSpa 8 automated incubator enables efficient multi-plate live-cell analysis.

Zapata AI Earns Second DARPA Award for Quantum Benchmarking

Retrieved on: 
Tuesday, November 28, 2023

Zapata Computing, Inc. (“Zapata AI” or the “Company”), the Industrial Generative AI software company developing solutions and applications to solve enterprises’ hardest problems, today announced that the company, along with several academic and technology partners, has been selected as an awardee for the second phase of the Defense Advanced Research Projects Agency (DARPA) Quantum Benchmarking program.

Key Points: 
  • Zapata Computing, Inc. (“Zapata AI” or the “Company”), the Industrial Generative AI software company developing solutions and applications to solve enterprises’ hardest problems, today announced that the company, along with several academic and technology partners, has been selected as an awardee for the second phase of the Defense Advanced Research Projects Agency (DARPA) Quantum Benchmarking program.
  • The multi-year, multi-million-dollar award will help the quantum computing community identify the resources required to deliver quantum applications with high utility for industrial problems.
  • The Phase II award builds on the Phase I award granted to the same group of collaborators in 2022.
  • “This latest DARPA award will help us to better quantify the impact of our quantum hardware across industries and business practices, and assess and improve the timeline to practical commercial advantage.” In addition to the efforts with DARPA, Zapata AI and IonQ also recently announced a new strategic alliance to benchmark Industrial Generative AI techniques on quantum hardware.

Oxford Instruments Asylum Research releases VERO, an Interferometric AFM

Retrieved on: 
Monday, November 27, 2023

Oxford Instruments Asylum Research announces today the release of Vero, the first and only AFM with Quadrature Phase Differential Interferometry (QPDI) cantilever sensing technology.

Key Points: 
  • Oxford Instruments Asylum Research announces today the release of Vero, the first and only AFM with Quadrature Phase Differential Interferometry (QPDI) cantilever sensing technology.
  • “This exciting new product builds on Asylum Research’s rich tradition of leading innovation within the AFM market.
  • “The introduction of QPDI cantilever sensing will be a major breakthrough for the AFM research community,” said Dr. Roger Proksch, Chief Technology Officer for Asylum Research.
  • Join Asylum Research for an e-seminar “Quadrature Phase Differential Interferometry (QPDI) Technology in the Asylum Research Vero AFM” on December 6 at 8am PT.

Global Quantum Technologies Market 2024-2034 Report Reveals Quantum Revolution Potential - ResearchAndMarkets.com

Retrieved on: 
Monday, November 27, 2023

The "Global Market for Quantum Technologies 2024-2034" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Market for Quantum Technologies 2024-2034" report has been added to ResearchAndMarkets.com's offering.
  • The global quantum technologies market is an emerging industry with the potential to revolutionize computing, cryptography, sensing, imaging, and communications.
  • The Global Market for Quantum Technologies 2024-2034 is a comprehensive 400 page overview of the global quantum technology industry, companies, research trends, applications, and future roadmap across computing, cryptography, cybersecurity, communications, sensing, materials science, and more.
  • Companies profiled include Diraq, LQUOM, memQ, Nanofiber Quantum Technologies, Nomad Atomics, Oxford Ionics, PASQAL, Planckian, Polaris Quantum Biotech (POLARISqb), PsiQuantum, Quantum Bridge, QUANTier, Quantum Brilliance, Quantum Motion, Quside Technologies S.L., Quobly, SemiQon, Silicon Extreme, Silicon Quantum Computing (SQC) and Sparrow Quantum.

LTIMindtree Launches and Tests Quantum-Safe VPN Link in London in Collaboration with Quantum Xchange & Fortinet

Retrieved on: 
Thursday, November 23, 2023

LTIMindtree's Quantum-Safe VPN platform is realized in close collaboration with its partners Quantum Xchange, a leader in quantum-safe communication solutions, and Fortinet, the global cybersecurity leader driving the convergence of networking and security.

Key Points: 
  • LTIMindtree's Quantum-Safe VPN platform is realized in close collaboration with its partners Quantum Xchange, a leader in quantum-safe communication solutions, and Fortinet, the global cybersecurity leader driving the convergence of networking and security.
  • Quantum Xchange provides the quantum hardware and software that enable the generation, distribution, and management of quantum keys, while Fortinet’s FortiGate firewall provides the VPN functionality that integrates quantum-safe keys with standards-based VPN protocols.
  • LTIMindtree leverages its integration and domain expertise to implement and operate the Quantum-Safe VPN link across its active network.
  • Eddy Zervigon, CEO of Quantum Xchange, said, “Joining forces with LTIMindtree for this innovative quantum-safe VPN project is the start of a forward-thinking partnership.